Odevixibat Safe for Alagille Syndrome Based on Hepatic Changes
Pooled phase 3 data presented at North American Society for Pediatric Gastroenterology, Hepatology & Nutrition 2023 support the benefit-risk profile of the ileal bile acid transport inhibitor in treating the rare liver disease.
Oral Biotherapeutic ADS024 Safe, Tolerable for Recurrent C difficile Prevention
New phase 1B data support further investigation into Adiso Therapeutic's prospective treatment.
FDA Denies Marketing to 6 Vuse Alto Flavored e-Cigarette Products
The marketing denial orders were due to what the FDA stated as insufficient data supporting the products' additional benefit for adults switching from smoking cigarettes to vaping or cessation.
Daily Oral Paltusotine Maintains Acromegaly Treatment Benefit in Phase 3 Trial
Crinetics announced findings from the PATHFNDR-1 trial showing the investigative oral daily drug may provide patients with the rare disease an alternative from recurring injection therapy.
Patients With Crohn's Disease Report Low Calcium, Magnesium Intake
A study from China suggests calcium and magnesium malnutrition is associated with Crohn's disease inflammation and activity.
Children With Asthma Have Greater Risk of Sleep-Disordered Breathing
Children with severe and poorly controlled asthma generally face a greater risk of sleep-disordered breathing.
2 Clarke Drive Cranbury, NJ 08512